Posted on 7/23/18
Sanofi Ventures Leads $17 Million Financing of Click Therapeutics
Click Therapeutics, Inc. a leader in Digital Therapeutics solutions as prescription medical treatments, announces a $17 million financing round led by Sanofi Ventures.
Posted on 7/23/18
Your Daily Pharma Scoop: Catalyst Bio Succeeds, CTI Moves Forward, Pfizer Positive
SummaryCatalyst Bio succeeds in Phase 2/3 trial.CTI plans to launch Phase 3 trial.Pfizer announces successful Phase 3 data.This idea was discussed in more depth with members . . .
Posted on 7/23/18
Better Buy: Eli Lilly and Company vs. Merck & Co.
Big pharma stocks have enjoyed investors' favor for a long time. They usually generate lots of cash that can be reinvested for growth, and that can . . .
Posted on 7/19/18
Provention Bio Closes Upsized IPO
Provention Bio, Inc. (Nasdaq:PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the closing of its initial public offering of . . .
Posted on 7/19/18
Bristol-Myers Squibb and Gritstone Oncology Announce Clinical Research Collaboration
EMERYVILLE, Calif. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Gritstone Oncology today announced that the companies have entered into a clinical trial collaboration to . . .
Posted on 7/19/18
Why Johnson & Johnson Is An Attractive Investment
SummaryJohnson & Johnson has steadily performed during every economic cycle.The company is one of two with a AAA credit rating.The recent verdict will be appealed, even . . .
Posted on 7/19/18
Cara Therapeutics Prices $85.5M Offering of Common Stock
STAMFORD, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 7/18/18
The Picture for Cara Therapeutics Just Got Clearer
Shareholders of small-cap biotech Cara Therapeutics (NASDAQ:CARA) have had a bumpy ride the last couple of years. Hopes were flying high in early 2017, only to . . .
Posted on 7/18/18
Tenable Seeks $166 Million In U.S. IPO
SummaryTenable Holdings aims to raise $166 million from the sale of its common stock in an IPO.The firm provides cyber security risk assessment and compliance software . . .
Posted on 7/18/18
Fortress Biotech: Highly Complex, Greatly Undervalued
SummaryFortress Biotech is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.Company assets include interests in ten biotech companies, three of . . .
Posted on 7/18/18
Johnson & Johnson: Wait For The Outcome
SummaryJohnson & Johnson was handed a $4.7 billion product-liability verdict last week, the 6th largest in US history.Though company lawyers have found appellate success recently, this . . .
Posted on 7/18/18
Johnson & Johnson Looks Too Cheap
SummaryA continuation off a solid fiscal 2017; management has this blue-chip heading in the right direction.The company maintains its fortress balance sheet with its AAA S&P . . .
Posted on 7/18/18
The Wonder Of Johnson & Johnson
SummaryThe stock will ebb and flow but be in it for the dividend growth.We discuss the key takeaways from the most recent quarter, including strengths and . . .
Posted on 7/18/18
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) ranks as the world's largest healthcare company. However, the healthcare giant has been under fire somewhat so far in 2018. J&J stock . . .
Posted on 7/18/18
Johnson & Johnson (JNJ) Q2 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Johnson & Johnson (NYSE:JNJ)Q2 2018 Earnings Conference CallJuly 17, 2018, 8:30 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning and welcome to . . .
Posted on 7/18/18
What's Behind Johnson & Johnson's Double-Digit Growth?
Johnson & Johnson (NYSE:JNJ) is a healthcare giant that racks up tens of billions of dollars in revenue every quarter. Usually, it's tough to deliver double-digit . . .
Posted on 7/17/18
Cara Therapeutics Proposes Common Stock Offering
STAMFORD, Conn., July 17, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 7/17/18
RSC Solutions Launches RSC Healthcare LLC, Expands Footprint In Healthcare Industry
RSC Solutions, a leading technology services company, today announced the launch of its healthcare staffing division under the banner of RSC Healthcare LLC. RSC Healthcare LLC . . .
Posted on 7/17/18
White Oak Healthcare Finance Provides $20 Million for Celerity Partners’ Acquisition of Total Care Rx
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC today announced it acted as sole lender and administrative agent on the funding of a $20.65 million senior credit facility . . .
Posted on 7/17/18
UnitedHealth Group Reports Second Quarter Results
NEW YORK--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) reported second quarter results, with continued strong, well-diversified performance across the enterprise.“Today, UnitedHealth Group delivers increasing value to more people, . . .
Posted on 7/17/18
Pfizer's Reorganizing Again. Is Its Stock a Buy Now?
Last week, Pfizer (NYSE:PFE) announced that it was splitting its operating segments into three divisions. The company presently operates under a two-unit system: Innovative Health and . . .
Posted on 7/17/18
Aquestive Therapeutics Readies $60 Million IPO
Quick TakeAquestive Therapeutics (AQST) intends to raise $60 million in an IPO of its common stock, according to an amended registration statement.The company is advancing a . . .
Posted on 7/17/18
Targeted Oncology Partners with The International Liver Cancer Association
CRANBURY, N.J.--(BUSINESS WIRE)--Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, becomes partners with the International Liver . . .
Posted on 7/16/18
HSS Receives $5.6 Million Grant
Hospital for Special Surgery (HSS), known for its leadership in musculoskeletal care, is at the forefront of functional genomics for autoimmune diseases thanks to pioneering research . . .
Posted on 7/16/18
Bioasis Announces Non-Brokered Private Placement
RICHMOND, British Columbia & GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF), a biopharmaceutical company developing its xB3 proprietary platform technology for the delivery of therapeutics across . . .

